Director/PDMR Shareholding

About this update from Convatec Group Plc

17 March 2026 Convatec Group Plc ("Convatec" or "the Company") Director/PDMR Shareholding  The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares"). Vesting of Awards under the Company's Long Term Incentive Plan ("LTIP") and Deferred Bonus Plan ("DBP") On 15 March 2026, conditional share awards granted to each of Jonny Mason, Chief Executive Officer and Fiona Ryder, Chief Financial Officer in 2023 under the LTIP in the form of Performance Share Awards ("PSA") vested and were released to them on 16 March 2026. Additionally, on 15 March 2026, awards granted to each of Jonny Mason in 2023 under the DBP in the form of Restricted Stock Units ("RSU") and awards granted to Fiona Ryder in 2023 under the LTIP in the form of RSUs also vested and were released to them on 16 March 2026. For all awards released to the PDMRs, on 16 March 2026 sufficient shares were sold to satisfy income tax and National Insurance ("NI") liabilities , with the balance of shares retained by the PDMRs, as summarised in the table below: PDMR Share Award Shares vested Shares sold to satisfy income tax & NI liabilities Share price Total shares acquired Jonny Mason PSA 511,469   241,114 £2.344 270,355 Jonny Mason DBP 106,137 50,035 £2.344 56,102 Fiona Ryder   PSA 27,001 12,729 £2.344 14,272 Fiona Ryder   RSU 31,748 14,967 £2.344 16,781   NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1   Details of the person discharging managerial responsibilities / person closely associated a)   Name   Jonny Mason 2   Reason for the notification   a)   Position/status   Chief Executive Officer and PDMR b)   Initial notification /Amendment   Initial Notification 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)   Name   Convatec Group Plc b)   LEI   213800LS272L4FIDOH92 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   a)   Description of the financial instrument, type of instrument Ordinary share of 10p each in Convatec Group Plc Identification code GB00BD3VFW73 b)   Nature of the transaction     a.    Vesting of PSA under the LTIP. b.    Vesting of RSU under the DBP.   c) Price(s) and volume(s)           Price(s) Volume(s) a. £0 511,469 b. £0 106,137 d)   Aggregated information - Aggregated volume 617,606 - Price £0 e)   Date of the transaction   2026-03-15 f)   Place of the transaction   Outside a trading venue 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   a)   Description of the financial instrument, type of instrument Ordinary share of 10p each in Convatec Group Plc Identification code GB00BD3VFW73 b)   Nature of the transaction     a.    Immediate sale of shares awarded under the LTIP to cover tax and national insurance liabilities. b.    Immediate sale of shares awarded under the DBP to cover tax and national insurance liabilities. c) Price(s) and volume(s)           Price(s) Volume(s) a. £2.344 241,114 b. £2.344 50,035 d)   Aggregated information - Aggregated volume 291,149 - Price £2.344 e)   Date of the transaction   2026-03-16 f)   Place of the transaction   XLON   1   Details of the person discharging managerial responsibilities / person closely associated a)   Name   Fiona Ryder 2   Reason for the notification   a)   Position/status   Chief Financial Officer and PDMR b)   Initial notification /Amendment   Initial Notification 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a)   Name   Convatec Group Plc b)   LEI   213800LS272L4FIDOH92 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   a)   Description of the financial instrument, type of instrument Ordinary share of 10p each in Convatec Group Plc Identification code GB00BD3VFW73 b)   Nature of the transaction     a.    Vesting of PSA under the LTIP. b.    Vesting of RSU under the LTIP.   c) Price(s) and volume(s)           Price(s) Volume(s) a. £0 27,001 b. £0 31,748 d)   Aggregated information - Aggregated volume 58,749 - Price £0 e)   Date of the transaction   2026-03-15 f)   Place of the transaction   Outside a trading venue 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   a)   Description of the financial instrument, type of instrument Ordinary share of 10p each in Convatec Group Plc Identification code GB00BD3VFW73 b)   Nature of the transaction     a.    Immediate sale of shares awarded under the LTIP to cover tax and national insurance liabilities. b.    Immediate sale of RSUs awarded under the LTIP to cover tax and national insurance liabilities. c) Price(s) and volume(s)           Price(s) Volume(s) a. £2.344 12,729 b. £2.344 14,967 d)   Aggregated information - Aggregated volume 27,696 - Price £2.344 e)   Date of the transaction   2026-03-16 f)   Place of the transaction   XLON   Enquiries   James Kerton, Company Secretary                                                                       Email: [email protected]       Convatec Group Plc's LEI code is 213800LS272L4FIDOH92 Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation About Convatec   Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com    

View stock analysis, news, and events for Convatec Group Plc